Literature DB >> 17119192

Interpreting cancer trends.

Elizabeth M Ward1, Michael J Thun, Lindsay M Hannan, Ahmedin Jemal.   

Abstract

The interpretation of cancer incidence trends is complicated by short-term random variation, artifactual fluctuations introduced by screening, changes in diagnosis or disease classification, completeness of reporting, and by the multiplicity of factors that may affect risk for specific cancer sites. We analyzed trends in 56 different cancer sites and subsites in the U.S. SEER registries in the period 1975-2002 using join-point analysis. The increase in cancer incidence for all sites combined that became evident with the inception of the SEER registries in the mid-1970s has abated since the early 1990s. Among the 15 most common cancer sites in men, sites with increasing incidence rates during the most recent time period include melanoma of the skin and cancers of the prostate, kidney and renal pelvis (kidney), and esophagus. Among women, incidence rates are increasing for leukemia, non-Hodgkin's lymphoma, melanoma, and cancers of the breast, thyroid, urinary bladder, and kidney. Incidence rates for all childhood cancers combined increased 0.6% per year from 1975 to 2002. Cancer mortality rates have decreased in the United States since 1991 in both men and in women; site-specific death rates have decreased in the most recent time period for 12 of the top 15 cancer sites in men and 9 of the top 15 cancer sites in women. Similar trends in cancer incidence and mortality have been reported in other industrialized countries. Possible reasons for these trends are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 17119192     DOI: 10.1196/annals.1371.048

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  20 in total

1.  The effect of a novel frizzled 8-related antiproliferative factor on in vitro carcinoma and melanoma cell proliferation and invasion.

Authors:  Kristopher R Koch; Chen-Ou Zhang; Piotr Kaczmarek; Joseph Barchi; Li Guo; Hanief M Shahjee; Susan Keay
Journal:  Invest New Drugs       Date:  2011-09-20       Impact factor: 3.850

Review 2.  Endocrine-disrupting chemicals: associated disorders and mechanisms of action.

Authors:  Sam De Coster; Nicolas van Larebeke
Journal:  J Environ Public Health       Date:  2012-09-06

3.  NFAT1 Directly Regulates IL8 and MMP3 to Promote Melanoma Tumor Growth and Metastasis.

Authors:  Einav Shoshan; Russell R Braeuer; Takafumi Kamiya; Aaron K Mobley; Li Huang; Mayra E Vasquez; Guermarie Velazquez-Torres; Nitin Chakravarti; Cristina Ivan; Victor Prieto; Gabriel J Villares; Menashe Bar-Eli
Journal:  Cancer Res       Date:  2016-03-24       Impact factor: 12.701

4.  Mechanisms regulating enhanced human leukocyte antigen class II-mediated CD4 + T cell recognition of human B-cell lymphoma by resveratrol.

Authors:  Faisal F Y Radwan; Lixia Zhang; Azim Hossain; Bently P Doonan; Jason M God; Azizul Haque
Journal:  Leuk Lymphoma       Date:  2011-10-24

5.  Lead, calcium uptake, and related genetic variants in association with renal cell carcinoma risk in a cohort of male Finnish smokers.

Authors:  Emily B Southard; Alanna Roff; Tracey Fortugno; John P Richie; Matthew Kaag; Vernon M Chinchilli; Jarmo Virtamo; Demetrius Albanes; Stephanie Weinstein; Robin Taylor Wilson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-11-15       Impact factor: 4.254

6.  Atopic dermatitis is not a protective factor for melanoma but asthma may be.

Authors:  Enes Hajdarbegovic; Nasirah Atiq; Robert van der Leest; Bing Thio; Tamar Nijsten
Journal:  Int J Clin Oncol       Date:  2013-07-06       Impact factor: 3.402

7.  Melanoma-derived exosomes induce reprogramming fibroblasts into cancer-associated fibroblasts via Gm26809 delivery.

Authors:  Tairan Hu; Jiacai Hu
Journal:  Cell Cycle       Date:  2019-09-23       Impact factor: 4.534

Review 8.  The role of the PAX8/PPARgamma fusion oncogene in the pathogenesis of follicular thyroid cancer.

Authors:  Norman L Eberhardt; Stefan K G Grebe; Bryan McIver; Honey V Reddi
Journal:  Mol Cell Endocrinol       Date:  2009-10-31       Impact factor: 4.102

9.  Body size and renal cell cancer incidence in a large US cohort study.

Authors:  Kenneth F Adams; Michael F Leitzmann; Demetrius Albanes; Victor Kipnis; Steven C Moore; Arthur Schatzkin; Wong-Ho Chow
Journal:  Am J Epidemiol       Date:  2008-06-09       Impact factor: 4.897

10.  Trends in incidence of childhood cancer in Australia, 1983-2006.

Authors:  P D Baade; D R Youlden; P C Valery; T Hassall; L Ward; A C Green; J F Aitken
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.